ViaNautis
Cambridge, GB · 44 employees on LinkedIn · 2 known investors
ViaNautis develops targeted polyNaut nanovesicle (tPNV) delivery technology to advance cell and gene therapies and genetic medicines. A UCL spin-out originally established as SomaServe in 2018, the company operates from facilities in Cambridge, UK.
Founders & leadership
DA
Dr Adi Hoess
DR
Dr Ray Jupp
DS
Dr Samuel Barker
DS
Dr Sarah Wythe
SS
Sam Smart
Investors · 2
Frequently asked questions
- What does ViaNautis do?
- ViaNautis develops targeted polyNaut nanovesicle (tPNV) delivery technology to advance cell and gene therapies and genetic medicines. A UCL spin-out originally established as SomaServe in 2018, the company operates from facilities in Cambridge, UK.
- Who are ViaNautis's investors?
- ViaNautis's investors include Cambridge Angels group, Oxford Investment Opportunity Network (OION).
- Where is ViaNautis headquartered?
- ViaNautis is headquartered in Cambridge, GB.